澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

IMMURON LTD

0.030

0.000

成交量：- -

成交额：- -

市值：979.96万

市盈率：-1.30

高：0.030

开：0.030

低：0.030

收：0.030

52周最高：0.098

52周最低：0.026

股本：3.27亿

流通股本：2.65亿

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.023

每股收益(LYR):-0.023

净资产收益率：-39.68%

总资产收益率：-21.93%

市净率：0.75

市盈率(LYR):-1.33

数据加载中...

总览公司新闻资讯公告

IMMURON LTD作出战略决策：寻求合作伙伴为Travelan与IMM-529临床项目提供资金支持

Immuron宣布IMM-529的IND获得FDA批准

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IMC.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IMC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMC.AU\",,,,,undefined,":{"symbol":"IMC.AU","market":"AU","secType":"STK","nameCN":"IMMURON LTD","latestPrice":0.03,"timestamp":1774484767792,"preClose":0.03,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"IMMURON LTD","floatShares":265374293,"shares":326653609,"eps":-0.023,"marketStatus":"交易中","change":0,"latestTime":"03-26 12:19:07 AEDT","open":0.03,"high":0.03,"low":0.03,"amount":0,"amplitude":0,"askPrice":0.03,"askSize":29400,"bidPrice":0.028,"bidSize":184942,"shortable":3,"etf":0,"ttmEps":-0.023,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774501200000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.03,"openAndCloseTimeList":[[1774479600000,1774501200000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMC.AU","preClose":0.03,"auctionPrice":0.03,"auctionVolume":4424,"auctionTime":1774479546348,"referenceTime":1774431003096,"auction":1,"marketStatus":"盘前竞价","timestamp":1774479546348}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMC.AU\",,,,,undefined,":{"symbol":"IMC.AU","floatShares":265374293,"roa":"-21.93%","roe":"-39.68%","lyrEps":-0.022586,"shares":326653609,"dividePrice":0,"high":0.03,"amplitude":0,"preClose":0.03,"low":0.03,"week52Low":0.026,"pbRate":"0.75","psRate":"1.31","week52High":0.098,"institutionHeld":0,"latestPrice":0.03,"committee":0.725672,"eps":-0.023,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.023,"open":0.03,"prevYearClose":0.036,"prevWeekClose":0.027,"prevMonthClose":0.028,"prevQuarterClose":0.036,"fiveDayClose":0.027,"twentyDayClose":0.029,"sixtyDayClose":0.038},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMC.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-02-28","symbol":"IMC.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1677502800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMC.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1138357123","title":"IMMURON LTD作出战略决策：寻求合作伙伴为Travelan与IMM-529临床项目提供资金支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1138357123","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138357123?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 19:12","pubTimestamp":1772017927,"startTime":"0","endTime":"0","summary":"IMMURON LTD宣布已制定关键战略方针，将通过寻求外部合作的方式为旗下两款核心产品——Travelan与IMM-529的临床研究计划注入资金动力。该决策旨在加速推进两项临床项目的研发进程，同时优化公司资源分配结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"1125337681","title":"Immuron宣布IMM-529的IND获得FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1125337681","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125337681?lang=zh_cn&edition=fundamental","pubTime":"2025-11-20 00:42","pubTimestamp":1763570545,"startTime":"0","endTime":"0","summary":"11月5日 - Immuron Ltd宣布，*IMM-529的IND已获得FDA批准*。进一步的公司报道：IMC.AX","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","IMC.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}